Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors

Front Immunol. 2021 Jan 27:11:604967. doi: 10.3389/fimmu.2020.604967. eCollection 2020.

Abstract

In recent years, cancer immunotherapy experienced remarkable developments and it is nowadays considered a promising therapeutic frontier against many types of cancer, especially hematological malignancies. However, in most types of solid tumors, immunotherapy efficacy is modest, partly because of the limited accessibility of lymphocytes to the tumor core. This immune exclusion is mediated by a variety of physical, functional and dynamic barriers, which play a role in shaping the immune infiltrate in the tumor microenvironment. At present there is no unified and integrated understanding about the role played by different postulated models of immune exclusion in human solid tumors. Systematically mapping immune landscapes or "topographies" in cancers of different histology is of pivotal importance to characterize spatial and temporal distribution of lymphocytes in the tumor microenvironment, providing insights into mechanisms of immune exclusion. Spatially mapping immune cells also provides quantitative information, which could be informative in clinical settings, for example for the discovery of new biomarkers that could guide the design of patient-specific immunotherapies. In this review, we aim to summarize current standard and next generation approaches to define Cancer Immune Topographies based on published studies and propose future perspectives.

Keywords: deep learning; imaging techniques; immune exclusion; immune topography; single-cell analysis; solid tumors.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Gene Expression Profiling
  • Genetic Predisposition to Disease
  • Humans
  • Immunophenotyping
  • Neoplasms / diagnostic imaging*
  • Neoplasms / genetics
  • Neoplasms / immunology
  • Neoplasms / metabolism
  • Optical Imaging*
  • Phenotype
  • Predictive Value of Tests
  • Transcriptome
  • Tumor Microenvironment*

Substances

  • Biomarkers, Tumor